SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001628280-24-013290
Filing Date
2024-03-27
Accepted
2024-03-27 16:34:00
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 acumenpharma-sx3.htm S-3 337366
2 EX-FILING FEES exhibit107-sx3.htm EX-FILING FEES 35079
3 EX-4.2 exhibit42-sx3.htm EX-4.2 384002
4 EX-4.4 exhibit44-sx3.htm EX-4.4 127363
5 EX-4.5 exhibit45-sx3.htm EX-4.5 164512
6 EX-4.6 exhibit46-sx3.htm EX-4.6 150922
7 EX-5.1 exhibit51-sx3.htm EX-5.1 22871
8 EX-23.1 exhibit231-sx3.htm EX-23.1 2903
9 exhibit51a.jpg GRAPHIC 19943
10 eylogo.jpg GRAPHIC 40682
11 prospectuscover1a.jpg GRAPHIC 5381
  Complete submission text file 0001628280-24-013290.txt   1316945
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-278280 | Film No.: 24791328
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)